SIRPA and non-small cell lung carcinoma: Analysis of TAMs and CD47/SIRPα expression patterns did not reveal any association with the expression of PD-L1/PD-1, another important immune checkpoint pathway related to cytotoxic T-cell activity in NSCLC.